학술논문
A novel thromboxane receptor antagonist and synthase inhibitor, BM-573, reduces development and progression of atherosclerosis in LDL receptor deficient mice
Document Type
Article
Source
In European Journal of Pharmacology 2007 561(1):105-111
Subject
Language
ISSN
0014-2999